ArticlebioRxiv : the preprint server for biology2025
Interleukin-1 receptor antagonist is a conserved early factor for exacerbating tuberculosis susceptibility.
Ophelia V Lee, Daisy X Ji, Bruce A Rosa, David L Jaye, Sara Suliman, Makedonka Mitreva, Cem Gabay, Russell E Vance, Dmitri I Kotov
Open access · greenAbstract readPreprint
In one paragraphArticle in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed, 10 citations in OpenAlex.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
9 authors at 5 institutions in 2 countries.
Ophelia V LeeDivison of Immunology and Molecular Medicine, University of California, Berkeley, Berkeley, CA, 94720, USA.
Daisy X JiDepartment of Microbiology, New York University Grossman School of Medicine, New York, NY, 10016, USA.
Bruce A RosaDivision of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St. Louis, MO, 63110, USA.ORCID 0000-0002-6820-446X David L JayeDepartment of Pathology and Laboratory Medicine, Emory University, Atlanta, GA, 30322, USA.
Sara SulimanDivision of Experimental Medicine, Department of Medicine, University of California, San Francisco, San Francisco, CA, 94115, USA.
Makedonka MitrevaDivision of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St. Louis, MO, 63110, USA.
Cem GabayDivision of Rheumatology, Department of Medicine, University Hospital of Geneva, Geneva, Switzerland.
Russell E VanceDivison of Immunology and Molecular Medicine, Howard Hughes Medical Institute, University of California, Berkeley, Berkeley, CA, 94720, USA.ORCID 0000-0002-6686-3912 Dmitri I KotovDivision of Infectious Diseases, Department of Medicine, Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs, Washington University School of Medicine, St. Louis, MO, 63110, USA.ORCID 0000-0001-7843-1503 Howard Hughes Medical Institute · USWashington University in St. Louis · USEmory University · USNew York University · USUniversity of California, San Francisco · US
Funding
The role of Listeria cyclic-di-AMP during infection and immunityP01AI063302 · NIAID · UNIVERSITY OF CALIFORNIA BERKELEY · PI PORTNOY, DANIEL A · 2004 to 2025
$45.5MFunctional and Structural Dissection of Inflammasome ActivationR37AI075039 · NIAID · UNIVERSITY OF CALIFORNIA BERKELEY · PI RUSSELL E VANCE · 2018 to 2026
$3.8MSpecificity and in vivo function of the Naip/Nlrc4 inflammasomesR01AI075039 · NIAID · UNIVERSITY OF CALIFORNIA BERKELEY · PI VANCE, RUSSELL E · 2008 to 2017
$3.6MThe role of tyrosine metabolism in tuberculosis pathogenesisR01AI175614 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Sara Suliman · 2023 to 2026
$3.3MDissection of Shigella pathogenesis in vivo using a new oral infection mouse modelR01AI155634 · NIAID · UNIVERSITY OF CALIFORNIA BERKELEY · PI VANCE, RUSSELL E · 2020 to 2024
$2.2MIn vivo mechanisms of Mycobacterium tuberculosis control and susceptibilityF32HL158250 · NHLBI · UNIVERSITY OF CALIFORNIA BERKELEY · PI KOTOV, DMITRI I · 2022 to 2024
$210kNHLBI NIH HHS F32 HL158250NIAID NIH HHS P01 AI063302NIAID NIH HHS R01 AI075039NIAID NIH HHS R01 AI155634NIAID NIH HHS R01 AI175614NIAID NIH HHS R37 AI075039
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
IL-1 receptor antagonistInnate immunitymacrophageneutrophilosteopontinSpp1tuberculosis
Identifiers
PMID37961447
PMCPMC10634924
OpenAlexW4388164405
What Socratic holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390